Association between celiac disease and chronic hepatitis C

Area of Science:

• Gastroenterology
• Immunology
• Hepatology

Background:

• Celiac disease involves gluten-induced small bowel damage and malabsorption in susceptible individuals.
• Non-intestinal inflammatory conditions, like Hepatitis C virus (HCV) infection, may trigger gluten intolerance.
• Interferon therapy for HCV can potentially unmask silent celiac disease.

Purpose of the Study:

• To investigate the potential association between HCV infection and celiac disease.
• To evaluate the role of interferon therapy in precipitating celiac disease symptoms.
• To determine the appropriateness of celiac disease screening in HCV patients.

Main Methods:

• Review of existing literature on celiac disease, HCV, and interferon therapy.
• Analysis of reported cases of celiac disease symptoms during interferon treatment.
• Evaluation of serological markers for celiac disease, such as anti-transglutaminase antibodies.

Main Results:

• A definitive association between chronic HCV hepatitis and celiac disease is difficult to establish based on current data.
• Symptoms like diarrhea, anemia, and weight loss during interferon therapy may indicate celiac disease, correlating with positive anti-transglutaminase antibody tests.
• Pre-treatment celiac disease screening in HCV patients receiving interferon is not strongly supported by evidence.

Conclusions:

• Routine celiac disease screening before interferon therapy for HCV is not recommended.
• Consider celiac disease serology in HCV patients who develop gastrointestinal symptoms or weight loss during interferon treatment.
• Further research may be needed to clarify the complex interplay between HCV, interferon therapy, and celiac disease.